Advertisement Physio-Control wins FDA clearance for Lifepak 15 monitor/defibrillator - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Physio-Control wins FDA clearance for Lifepak 15 monitor/defibrillator

Physio-Control, a wholly owned subsidiary of Medtronic, has received clearance from the FDA to market the Lifepak 15 monitor/defibrillator within the US.

Brian Webster, president of Physio-Control, said: “With the Lifepak 15 monitor/defibrillator, Physio-Control is delivering on its commitment to provide innovative, reliable and durable equipment to emergency personnel so they can focus on the most important task at hand – saving lives.

“This industry was built on the innovations delivered by Physio-Control and the Lifepak 15 monitor continues to define the new standard for emergency care products.”